Navigation Links
CRi Announces Maestro 2, the Next Generation in Vivo Optical Imaging Systems
Date:11/26/2007

WOBURN, Mass., Nov. 26 /PRNewswire/ -- Cambridge Research & Instrumentation, Inc. (CRi) announces the launch of Maestro 2 optical imaging systems in North America. The Maestro 2 received widespread acclaim at the both the recent Society of Molecular Imaging/Academy of Molecular Imaging joint conference for in vivo imaging, and at the Stanford University Small Animal Imaging Workshop as well. Maestro 2, the fully automated version of the award-winning Maestro small animal imaging system, is the ideal optical imaging system for both core imaging facilities and individual laboratories using fluorescence-based imaging methodologies.

Maestro 2 combines the sensitivity and features of the original Maestro in vivo imaging system with advanced animal handling features -- an integrated anesthesia system and temperature controlled stage and imaging chamber. Computer-controlled automation through a new, user-friendly interface provides easy zoom and focus adjustments and a rapid selection of a full range of excitation and emission filters. The Flex(TM) liquid crystal tunable filter (LCTF) provides fast, accurate spectral imaging from 500 to 950 nm, covering the full range of available in vivo fluorophores. The fully automated system allows easy instrument setup and calibration for faster, more accurate results within and between experiments. Maestro 2 provides increased sensitivity, automatic removal of autofluorescence for increase spectral contrast, and improved quantification of experimental results.

The Flex LCTF technology provides more accurate multiplexing capability and better quantification of experimental results. The software includes the Real Component Analysis(TM) (RCA) algorithm for automatic identification of spectral signatures and the Compute Spectra(TM) tool, which automatically separates combined or overlapping spectral signatures, enabling the end-user to build spectral libraries quickly and to rapidly analyze data. Quantitative measurement tools include component segmentation and regions of interest (ROI) analysis. Spatial, temporal and spectral separation of multiple signals are all enabled in the new Maestro 2, resulting in improved detection and quantification of co-localized signals in vivo.

"We are very excited about the Maestro 2 In Vivo Imaging System", says James Mansfield, Director of Multispectral Imaging Systems at CRi. "From its ergonomic design, optimized optics and user-friendly software tools, this system was designed and developed with the customers' needs in mind."

CRi, a Boston-based biomedical imaging company, has provided innovative optical imaging solutions for its customers for more than 20 years. A multidisciplinary team is dedicated to working with academic and commercial customers to provide high-value solutions. CRi provides comprehensive imaging and analysis solutions that enable the user to investigate and characterize biological phenotypes while preserving spatial context. With over 80 patents issued and pending, CRi's solution platforms encompass sub-cellular, cellular and whole animal applications. CRi's innovations are being utilized around the world to enable new breakthroughs in research, health and medicine. For more information visit our website at http://www.cri-inc.com or contact:

David Daniels, Ph.D.

Director of Marketing

CRi

35-B Cabot Road, Woburn, MA 01801 USA

Tel: 1-781-935-9099, extension 149

E-mail: ddaniels@cri-inc.com


'/>"/>
SOURCE Cambridge Research & Instrumentation, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 20, 2017 , ... Nipro Corporation (Osaka, Japan) and Transonic ... which Nipro will receive exclusive marketing and sales rights for all non-OEM Transonic products ... hemodialysis patients in Japan, the new Nipro - Transonic JV is a natural next ...
(Date:1/21/2017)... Jan. 20, 2017 Bioptix, Inc. ... announced that on January 14, 2017 the Board of ... the Company will terminate certain employees associated with the ... The Company commenced terminations on January 16, 2017 and ... The Company may pay severance benefits in certain circumstances ...
(Date:1/20/2017)... ... January 20, 2017 , ... The two newest companies ... options for patients. Vironika, a spin out from The Wistar Institute, and Sanguis, launched ... space at 3624 Market Street. , Vironika is developing a treatment for a ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Health Organization, cancer is one of leading causes of ... in 2012. Although the number of cancer related deaths ... since 1990. Rising in incidence rate of various cancers ... According to a research report by Global Market Insights, ...
Breaking Biology Technology:
(Date:1/19/2017)... 19, 2017 Sensory Inc ., ... security for consumer electronics, and i ... and cybersecurity solutions, today announced a global partnership ... institutions worldwide to bolster security of data sensitive ... user authentication platforms they offer, innerCore now offers ...
(Date:1/13/2017)... 2017 Sandata Technologies, LLC, a leading ... industry, including Electronic Visit Verification™ (EVV™), announced today ... as Senior Vice President of Product Management. ... homecare experience to Sandata, where he will be ... align Sandata,s suite of solutions with the needs ...
(Date:1/12/2017)... , January 12, 2017 A new report by Allied Market ... the global biometric technology market is expected to generate revenue of $10.72 billion by ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
Breaking Biology News(10 mins):